2023/06/01 08:02:50 | |
---|---|
Price | |
476.90 EUR | |
Difference | -0.69% (-3.30) |
ISIN | US8835561023 |
Symbol | TMO |
Exchange | Munich |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 187,345 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 476.90 EUR |
High | 476.90 EUR |
Low | 476.90 EUR |
Close (prev. day) | 480.20 EUR |
VWAP | 480.20 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2023/06/01 |
![]() |
Global Equity Ratings |
![]() |
2023/05/24 |
![]() |
Global Equity Ratings |
![]() |
2023/05/03 |
![]() |
Global Equity Ratings |
![]() |
2023/04/25 |
![]() |
Global Equity Ratings |
![]() |
2023/03/28 |
![]() |
Global Equity Ratings |
![]() |
2023/06/01 08:02:50 | |
---|---|
Price | |
476.90 EUR | |
Difference | -0.69% (-3.30) |
ISIN | US8835561023 |
Symbol | TMO |
Exchange | Munich |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 187,345 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 476.90 EUR |
High | 476.90 EUR |
Low | 476.90 EUR |
Close (prev. day) | 480.20 EUR |
VWAP | 480.20 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -9.90% | -9.87% | +52.78% |
Perf (abs.) | -52.40 | -52.20 | +164.75 |
Beta | 0.92 | 0.98 | 0.87 |
Volatility | 22.17 | 24.67 | 26.79 |
Ø price 5 days | Ø volume 5 days (pcs.) | 482.90 EUR (10) |
Ø price 30 days | Ø volume 30 days (pcs.) | 492.44 EUR (3) |
Ø price 100 days | Ø volume 100 days (pcs.) | 515.92 EUR (3) |
Ø price 250 days | Ø volume 250 days (pcs.) | 526.13 EUR (9) |
YTD High | date | 554.40 EUR (2023/01/24) |
YTD Low | date | 475.90 EUR (2023/05/25) |
52 Weeks High | date | 597.70 EUR (2022/08/16) |
52 Weeks Low | date | 475.90 EUR (2023/05/25) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/06/01 | 17:35 | 482.60 EUR | 0.02 | 11 |
Vienna Stock Exchange | 2023/06/01 | 17:32 | 482.70 EUR | 0.00 | 2 |
Tradegate | 2023/06/01 | 22:26 | 482.80 EUR | 0.38 | 76 |
Stuttgart | 2023/06/01 | 21:55 | 482.40 EUR | 0.07 | 9 |
NYSE | 2023/06/01 | 22:00 | 519.38 USD | 949.01 | 40,472 |
Munich | 2023/06/01 | 08:02 | 476.90 EUR | 0.00 | 1 |
London Stock Exchange | 2023/06/01 | 16:36 | 516.47 USD | 0.07 | 13 |
Frankfurt | 2023/06/01 | 18:01 | 483.70 EUR | 0.02 | 4 |
Duesseldorf | 2023/06/01 | 21:00 | 483.00 EUR | 0.00 | 10 |
Berlin | 2023/06/01 | 08:08 | 475.10 EUR | 0.00 | 1 |
BX Swiss | 2023/05/22 | 18:17 | 472.001 CHF | 0.00 | 1 |
THERMO FISHER SCIENTIFIC INC. |
- - |
168 Third Avenue - 02451 Waltham |
Telefon: +1-781-622-1000 |
Fax: +1-781-622-1207 |
E-mail: - |
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA. |
C. Harris | Member of Board of Directors |
Debora Spar | Member of Board of Directors |
Tyler Jacks | Member of Board of Directors |
Dion Weisler | Member of Board of Directors |
James Mullen | Member of Board of Directors |
Jim Manzi | Member of Board of Directors |
Lars Rebien Sørensen | Member of Board of Directors |
Nelson Chai | Member of Board of Directors |
R. Keith | Member of Board of Directors |
Ruby Chandy | Member of Board of Directors |
Scott Sperling | Member of Board of Directors |
Marc Casper | Chairman of Managing Board |
Alan Sachs | Member of Executive Committee |
David Johnston | Member of Executive Committee |
Garret Hampton | Member of Executive Committee |
Karen Nelson | Member of Executive Committee |
Aditya Joshi | Member of Executive Committee |
Anthony Smith | Member of Executive Committee |
Chetan Khanna | Member of Executive Committee |
Daniel Shine | Member of Executive Committee |
Daniella Cramp | Member of Executive Committee |
Frederick Lowery | Member of Executive Committee |
Gianluca Pettiti | Member of Executive Committee |
John Sabo | Member of Executive Committee |
Joseph Holmes | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer